Alexandra Karadimou

1.4k citations
28 papers · 959 indexed · h-index 14

Alexandra Karadimou

26 papers receiving 936 citations

Peers

Alexandra Karadimou
Comparison fields: 5 of 81
  • Oncology 479
  • Cancer Research 225
  • Pulmonary and Respiratory Medicine 464
  • Immunology 190
  • Molecular Biology 353
Replace Sertaç Yazıcı with:
Sertaç Yazıcı Türkiye
Hongdian Zhang China
Stephanie Petrillo Canada
Jene Choi South Korea
Johanna Münding Germany
Junzhou Wu China
Lucia D’Amico Italy
Bridget Charbonneau United States
Youyou Xia China
Magdalena Chechlińska Poland
Alexandra Karadimou relative to Sertaç Yazıcı Türkiye Sertaç Yazıcı's profile →
Citations per field
00.5×1.5×2.4×
Sertaç Yazıcı · 1×
Citations per year

Countries citing papers authored by Alexandra Karadimou

Since Specialization
Citations

This map shows the geographic impact of Alexandra Karadimou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Karadimou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Karadimou more than expected).

Fields of papers citing papers by Alexandra Karadimou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Karadimou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Karadimou. The network helps show where Alexandra Karadimou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexandra Karadimou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexandra Karadimou Line = papers co-authored together Alexandra Karadimou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 202214
3 2015230
4 201419
5 201427
6 20140
7 201370
8 20133
9 201286
10 201266
11 20116
12 20110
13 201117
14 2011249
15 201113
16 201124
17 201114
18 201024
19 201045
20 20109

About Alexandra Karadimou

Alexandra Karadimou is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 28 papers that have together received 959 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Renal and related cancers (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer, Lipids, and Metabolism (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Diagnosis and Treatment (3 papers) and Multiple and Secondary Primary Cancers (3 papers). The work is most often cited by research in Oncology (479 citations), Cancer Research (225 citations) and Pulmonary and Respiratory Medicine (464 citations). Alexandra Karadimou has collaborated with scholars based in Greece, France and Belgium. Frequent co-authors include Stéphane Oudard, Wolf H. Fridman, Meletios Α. Dimopoulos, Benoit Beuselinck, Aristotelis Bamias, Jessica Zucman‐Rossi, Hélène Péré, Alain Tedgui, Julien Taı̈eb and Cécile Badoual. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026